Recent studies have shown that targeting S100A4 has potential application value in tumor treatment [60, 61], and the regulatory association between STC1 and S100A4 proposed in this study also provides theoretical support for targeting S100A4 for tumor treatment. The gene discussed is STC1; the disease is neoplasm.